Juvena Therapeutics Is A Biotechnology Company Based In Redwood Citycaliforniafocused On Developing Innovative Biologic Therapies Derived From Stem Cell Secreted Proteinsfounded In 2018 By Drhanadie Yousefthe Company Utilizes Computational Biology And Ai Driven Analytics To Identify Therapeutic Proteins That Can Rejuvenate Tissues And Restore Function In Degenerativemetabolicand Rare Diseases Juvena Operates The Juvnet Platformwhich Analyzes Secretomes From Adult Stem Cells To Discover Proteins With Regenerative Propertiesthis Platform Includes High Throughput Screeningpredictive Analytics For Protein Disease Relationshipsand Preclinical Validation To Test Efficacy In Various Conditionsthe Company Has A Promising Product Pipelineincluding Juv 161 For Myotonic Dystrophy Type 1 And Juv 112 For Obesitywith Additional Programs Targeting Fibrotic Diseases And Metabolic Disordersjuvena Collaborates With Government Agenciespharmaceutical Companiesand Research Institutions To Advance Its Therapies And Expand Its Secretome Database
